Ashy dermatosis (Erythema dischromicum perstans);Dermatosis cenicienta (Eritema discrómico perstans)

Medicina Cutanea Ibero-Latino-Americana

Volumn 33, Issue 3, 2005, Pages 97-102

  López Bárcenas, Adriana ^a   Contreras Ruíz, José ^a   Carrillo Correa, Marisol ^a   Hojyo Tomoka, María Teresa ^a   Arenas, Roberto ^a   Domínguez Soto, Luciano ^a   Vega Memije, Elisa ^a  

^a HOSPITAL GENERAL DR MANUEL GEA GONZÁLEZ   (Mexico)

Author keywords

Ashy dermatosis; Dofazimine; Erythema dischromicum perstans

Indexed keywords

CLOFAZIMINE;

ASIA; BASAL CELL; BODY REGIONS; CELL VACUOLE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG EFFICACY; ERYTHEMA; ERYTHEMA DISCHROMICUM PERSTANS; HISTOPATHOLOGY; HUMAN; HYPERPIGMENTATION; LICHEN PLANUS; LYMPHOCYTIC INFILTRATION; PREVALENCE; REVIEW; SKIN PIGMENTATION; SOUTH AND CENTRAL AMERICA;

EID: 33846893212     PISSN: 02105187     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Mosher DB, Fitzpatrick TB, Ortonne JP, Hori Y. Dermatología en medicina general. Quinta edición. Argentina. Editorial Médica Panamericana. 2001:1058.
2. Vega-Memije ME, MD., Waxtein L, M.D., Arenas R, M.D., Hojyo-Tomak MT, M.D., Domínguez-Soto L. Ashy dermatosis and lichen planus pigmentosus: a clinicopathologic study of 31 cases. Int J Dermatol 1992;31:90-4.
3. Schwartz R, Erythema Dischromicum Perstans. www.emedicine.com/derm/ topic132.htm.2001.
4. Convit J, M.D., Piquera-Martín J, M.D., Pérez R, M.D. Erythema Dyschromicum Persians. Int J Dermatol 1989;28:168-9.
5. Combemale P, Faisant M, Guennoc B, Duplin M, Jean-Denis Heyraud. Erythema Dyschromicom Perstans: Report of a new case and critical review of the literature. J Dermatology 1998;25:747-53.
6. Novick L N, Phelps R Erythema Dyschromicum Persians. Int J Dermatol 1985;24:630-3
7. Knox J, Billy C, Freeman R. Erythema Dyschromicum Persians. Arch Dermatal 1968;97:263-72
8. Carvajal Huerta L, Uraga Pazmiño E, Loayza Vivanzo E, Sabando Sánchez R, García Ahaga I, Jeny E. Dermatitis Cenicienta. Med Cutan Iber Lat Am 1986;14:95-9
9. Domínguez-Soto L, Hojyo-Tomoka T, Vega-Memije E, Arenas R, Cortes-Franco R. Pigmentary problems in the tropics. Dermatol Clinics 1994;12:777-84
10. Vega E, Waxtein L, Arenas R, Hojyo-Tomoka T, Domínguez-Soto. L Ashy Dermatosis versus lichen planus pigmentosus: a controversial matter. Int J Dermatol 1992;31: 87-8
11. Miyagawa S, Komatsu M, Okuchi T, Shirai T, Sakamoto K. Erythema Dyschromicum perstans Immunopathologic studies. J Am Acad Dermatol 1989;20:882-6
12. Tschen J, Tschen E, McGavran M Erythema Dyschromicum Persians. J Am Acad Dermatol 1980;4:295-302
13. Arenas R, Bautista M. Dermatosis Cenicienta. Estudio de 8 pacientes tratados con clofazimina. Rev Colombiana Dermatol 1992;l:103-5
14. Arenas R. Atlas Diagnóstico y Tratamiento Dermatología. 2a Ed. México. Interamericana-McGraw-Hill Casa Editorial México 1996:92-3
15. Navarro Jiménez B, Sánchez Navarro L. Dermatosis Cenicienta (Erythema Dyschromicum Perstans): Estudio Prospective de 23 pacientes. Med Cut Iber Lat Am 1988;16:407-12.
16. Berger R, Hayes T, Dixon S. Erythema Dyschromicum Perstans and lichen planus: Are they related?. J Am Acad Dermatol 1989;21:438-442.
17. Leonforte J, Pelaez de Di B.O. Eritema discrómico persistente versus liquen piano. Med Cutan Iber Lat Am 1987;15:89-92
18. Sánchez NP, Pathak MA, Syozo S, Sato, Sânchez JL, Mihm MC, Fitzpatrick TB, Circumscribed Dermal Melaninoses: Classification, Light, Histochemical, and Electron Microscopic Studies on Three Patients with the Erythema Dyschromicum Persians Type. Int J Dermatol 1982;21:25-31.
19. Soter N.A, Wands C, Freeman R.G. Ultrastructural Pathology of Erythema Dyschromicum Perstans. J Invest Dermatol 1969;52:155-161.
20. Peachey R.D.G. South West of England and Wales Dermatology Society Ashy Dermatosis. J Dermatol 1976;94:227-8.
21. Baranda L, Torres-Alvarez B, Cortes-Franco R, Moncada B, Portales Pérez D, González-Amaro R. Involvement of Cell Adhesion and Activation Molecules in the Pathogenesis of Erythema Dyschromicum Persians (Ashy Dermatitis) The effect of Clozamine Therapy. Arch Dermatolol 1997;133:325-28
22. Jack L. Arbiser, M.D., Samuel L. Moscheila, M.D. Clofazimine: A Review of its medical uses and mechanisms of action. J Am Acad Dermatol 1995;32:241-7.